Major Category
Plastics & Rubber
Synonyms
Acrylamide monomer; Acrylic amide; Propenamide; 2-Propenamide; [NIOSH]
Description
White crystalline, odorless solid; [NIOSH]
Sources/Uses
Used as a polymer or copolymer to produce sealants, adhesives, fibers, paper sizing, molded parts, water coagulants, and textiles. "In the United States, 90% of acrylamide is used to produce polyacrylamide for water treatment (60%), pulp and paper production (20%) and mineral processing (10%);" [ACGIH]
Comments
Can cause sensorimotor neuropathy after occupational exposure; "Polyacrylamide, with less than 0.01% acrylamide, is nontoxic and considered safe as a cosmetic ingredient. . . . Available data indicate no unique sensitivity to the fetus. . . . Most cases of acrylamide poisoning in humans involved exposures over weeks or months from handling the monomer in the course of polymerization. . . . Kim et al. (2017) reported two cases of dermal and neural toxicity in Korean grouting workers with exposure to grouting agents that contained a high concentration of acrylamide (32 and 39% monomer)." [ACGIH] Allergic contact dermatitis reported in laboratory workers using polyacrylamide gels for electrophoresis; [Kanerva, p. 1738] "Germ cell mutagens that have shown to increase the mutant frequency in the progeny of exposed mammals." [MAK] Acrylamide (UN2074) has warning of explosive polymerization; [ERG 2016]
BEI
N-(2-Carbamoylethyl)valine (CbEv) in blood (not critical); BEI = 500 pmo/g globin (After 120 days of representative work/exposure to Acrylamide); S-(2-Carbamoylethyl)mercapturic acid (AAMA) in urine (end of shift); BEI = 800 ug/g creatine.
Skin Designation (ACGIH)
Yes
TLV (ACGIH)
0.03 mg/m3, inhalable fraction and vapor
Excerpts from Documentation for IDLHs
Calculations based on an oral LD50 of 150 to 180 mg/kg for guinea pigs, rabbits, and rats [McCollister et al. 1964] indicate that a worker should be able to escape within 30 minutes without injury or irreversible health effects from 600 mg/m3. . . . the revised IDLH for acrylamide is 60 mg/m3 based on being 2,000 times the OSHA PEL of 0.03 mg/m3 that was promulgated in 1989 (2,000 is an assigned protection factor for respirators; only the most reliable respirators are recommended above 2,000 times the OSHA PEL). [Note: NIOSH recommends as part of its carcinogen policy that the "most protective" respirators be worn for acrylamide at concentrations above 0.03 mg/m3.]
Vapor Pressure
0.007 mm Hg
Explosive Polymerization
Yes
Explanatory Notes
VP from HSDB;
Half Life
Plasma (animal studies): 2 days; whole body (animal studies): 6-18 days; [TDR, p. 40]
NFPA
high ambient temp required
IARC Carcinogen
Probable (2a)
NTP Carcinogen
Anticipated human carcinogen
ACGIH Carcinogen
Suspected Human
Diseases
Occupational diseases associated with exposure to this agent:
Processes
Industrial Processes with risk of exposure: